AstraZeneca’s Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer
Updated results from the positive PACIFIC Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) demonstrated a sustained, clinically meaningful ...
Read more